Literature DB >> 18538259

"Experimental" institutional models for corporate funding of academic research: unknown effects on the research enterprise.

Lisa Bero1.   

Abstract

Mesh：

Year:  2008        PMID： 18538259     DOI： 10.1016/j.jclinepi.2008.01.002

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN： 0895-4356            Impact factor:   6.437


× No keyword cloud information.
  4 in total

1.  The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).

Authors:  O Bruyere; J A Kanis; M-E Ibar-Abadie; N Alsayed; M L Brandi; N Burlet; D L Cahall; A Chines; J-P Devogelaer; W Dere; N Goel; N Hughes; J-M Kaufman; S Korte; B H Mitlak; D Niese; R Rizzoli; L C Rovati; J-Y Reginster
Journal:  Osteoporos Int       Date:  2010-03-18       Impact factor: 4.507

2.  "A delicate diplomatic situation": tobacco industry efforts to gain control of the Framingham Study.

Authors:  Janine K Cataldo; Lisa A Bero; Ruth E Malone
Journal:  J Clin Epidemiol       Date:  2010-08       Impact factor: 6.437

3.  Institutions' expectations for researchers' self-funding, federal grant holding, and private industry involvement: manifold drivers of self-interest and researcher behavior.

Authors:  Brian C Martinson; A Lauren Crain; Melissa S Anderson; Raymond De Vries
Journal:  Acad Med       Date:  2009-11       Impact factor: 6.893

4.  What Did I Do? Practitioner Awareness of Ethical Issues in Scientific Publishing.

Authors:  Ann Blair Kennedy; Albert Moraska; Grant Rich
Journal:  Int J Ther Massage Bodywork       Date:  2017-09-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.